Stock ScreenerStock IdeasHigh Risk, High RewardHigh Risk, High Reward StocksSpeculative companies with the highest upside potential according to WallStreet analysts. Proceed with extreme caution!
Stock ScreenerStock IdeasHigh Risk, High Reward
Consensus: Strong Buy + 1 more
Analysts: >= 2
Upside/Downside: >= 500%
| Ticker | Company | Zen Rating | Sentiment | Market Cap | Shares | Institutional % | Insider % | Net Insider (L12M) | Net Insider (L3M) |
|---|---|---|---|---|---|---|---|---|---|
| INAB | IN8BIO INC | $6.44M | 3,025,701 | 48.10% | 51.90% | Net Buying | Net Buying | ||
| PSTV | PLUS THERAPEUTICS INC | $10.47M | 32,717,054 | 1.19% | 71.44% | Net Buying | |||
| GBIO | GENERATION BIO CO | $20.11M | 67,035,236 | 60.72% | 39.28% | Net Buying | Net Selling | ||
| XFOR | X4 PHARMACEUTICALS INC | $10.59M | 5,788,686 | 93.26% | 6.74% | Net Selling | Net Buying | ||
| MRSN | MERSANA THERAPEUTICS INC | $36.27M | 124,631,339 | 33.53% | 66.47% | Net Selling | |||
| ACXP | ACURX PHARMACEUTICALS INC | $10.10M | 23,481,606 | 14.90% | 10.95% | Net Buying | |||
| FBLG | FIBROBIOLOGICS INC | $23.65M | 38,262,586 | 16.79% | 15.84% | Net Buying | Net Buying | ||
| BTAI | BIOXCEL THERAPEUTICS INC | $10.72M | 6,056,046 | 0.19% | 99.81% | Net Selling | |||
| IMNN | IMUNON INC | $10.82M | 14,620,732 | 2.34% | 63.55% | Net Buying | |||
| CODX | CO-DIAGNOSTICS INC | $8.87M | 33,712,530 | 17.34% | 29.41% | Net Selling | Net Selling | ||
| RVPH | REVIVA PHARMACEUTICALS HOLDINGS INC | $15.80M | 46,739,949 | 15.65% | 22.85% | ||||
| REE | REE AUTOMOTIVE LTD | $13.96M | 22,259,447 | 38.98% | 45.27% | ||||
| GRI | GRI BIO INC | $2.72M | 2,141,473 | 0.18% | 99.82% | ||||
| MBRX | MOLECULIN BIOTECH INC | $4.41M | 14,127,494 | 10.46% | 44.80% | Net Buying | Net Buying | ||
| WOLF | WOLFSPEED INC | $63.81M | 155,626,720 | 89.83% | 3.25% | Net Buying | Net Selling | ||
| CBUS | CIBUS INC | $48.48M | 34,384,554 | 20.44% | 79.56% | Net Buying | Net Buying | ||
| TNYA | TENAYA THERAPEUTICS INC | $99.23M | 162,666,931 | 29.61% | 23.54% | Net Buying | Net Selling | ||
| RANI | RANI THERAPEUTICS HOLDINGS INC | $31.76M | 57,542,105 | 6.27% | 38.43% | Net Selling | |||
| LFWD | LIFEWARD LTD | $7.38M | 11,007,592 | 0.74% | 99.26% | Net Selling | Net Selling | ||
| OKUR | ONKURE THERAPEUTICS INC | $32.42M | 13,510,399 | 32.03% | 67.97% | Net Buying | Net Selling | ||
| IGC | IGC PHARMA INC | $24.70M | 79,685,165 | 3.60% | 25.44% | Net Buying | |||
| ACRV | ACRIVON THERAPEUTICS INC | $37.63M | 31,355,361 | 60.12% | 39.88% | Net Selling | Net Selling | ||
| KAPA | KAIROS PHARMA LTD | $11.27M | 16,849,306 | 9.36% | 40.23% | Net Buying | |||
| ARTV | ARTIVA BIOTHERAPEUTICS INC | $35.81M | 24,363,119 | 57.07% | 42.93% | Net Buying | |||
| MTVA | METAVIA INC | $12.33M | 19,564,214 | 2.16% | 97.84% | Net Buying | Net Buying | ||
| IMUX | IMMUNIC INC | $67.07M | 95,817,536 | 42.22% | 16.57% | Net Buying | Net Buying | ||
| CGTX | COGNITION THERAPEUTICS INC | $18.60M | 61,993,046 | 18.76% | 41.39% | Net Selling | Net Selling | ||
| EKSO | EKSO BIONICS HOLDINGS INC | $6.49M | 1,936,199 | 12.26% | 87.74% | ||||
| UNCY | UNICYCIVE THERAPEUTICS INC | $82.03M | 12,062,928 | 80.89% | 19.11% | ||||
| DTIL | PRECISION BIOSCIENCES INC | $47.68M | 11,088,234 | 12.12% | 87.88% | Net Selling | Net Buying | ||
| ZURA | ZURA BIO LTD | $64.97M | 61,874,998 | 51.74% | 48.26% | Net Selling | |||
| CYBN | CYBIN INC | $163.01M | 20,001,406 | 39.14% | 0.00% | ||||
| OVID | OVID THERAPEUTICS INC | $21.48M | 71,109,514 | 65.25% | 24.06% | Net Selling | |||
| CABA | CABALETTA BIO INC | $79.67M | 50,743,101 | 71.55% | 8.32% | ||||
| SNSE | SENSEI BIOTHERAPEUTICS INC | $10.94M | 1,260,403 | 9.58% | 90.42% | Net Selling | |||
| OSTX | OS THERAPIES INC | $51.70M | 28,097,697 | 1.39% | 23.50% | Net Selling | Net Selling | ||
| IVVD | INVIVYD INC | $87.21M | 119,961,445 | 43.45% | 56.55% | Net Selling | |||
| IFRX | INFLARX NV | $54.74M | 67,747,130 | 25.86% | 0.00% | ||||
| PMN | PROMIS NEUROSCIENCES INC | $15.69M | 32,689,190 | 28.53% | 28.65% | Net Buying | |||
| JSPR | JASPER THERAPEUTICS INC | $82.47M | 15,022,122 | 20.68% | 79.32% | Net Buying | |||
| FEMY | FEMASYS INC | $26.70M | 27,239,885 | 14.16% | 8.37% | Net Buying | Net Buying | ||
| BOLT | BOLT BIOTHERAPEUTICS INC | $10.75M | 1,916,985 | 47.85% | 52.15% | Net Buying | |||
| GNLX | GENELUX CORP | $112.83M | 37,734,967 | 19.34% | 5.75% | Net Selling | Net Selling | ||
| GOVX | GEOVAX LABS INC | $14.59M | 15,193,593 | 0.46% | 99.54% | Net Buying | Net Buying | ||
| SDST | STARDUST POWER INC | $11.91M | 60,160,824 | 11.30% | 87.81% | Net Selling | Net Selling | ||
| ADVM | ADVERUM BIOTECHNOLOGIES INC | $48.47M | 20,890,733 | 33.55% | 66.45% | Net Buying | Net Buying | ||
| NKTX | NKARTA INC | $117.79M | 70,957,554 | 63.53% | 36.47% | Net Selling | Net Selling | ||
| NRXP | NRX PHARMACEUTICALS INC | $59.13M | 17,289,192 | 4.61% | 95.39% | Net Buying | |||
| CNTX | CONTEXT THERAPEUTICS INC | $59.20M | 89,704,194 | 79.60% | 1.46% | Net Buying | Net Buying | ||
| ENLV | ENLIVEX THERAPEUTICS LTD | $28.62M | 23,849,935 | 13.26% | 60.25% | ||||
| SGMO | SANGAMO THERAPEUTICS INC | $126.14M | 233,166,972 | 22.54% | 13.89% | Net Selling | Net Selling | ||
| FDMT | 4D MOLECULAR THERAPEUTICS INC | $177.89M | 46,324,642 | 77.31% | 22.69% | Net Buying | |||
| HOWL | WEREWOLF THERAPEUTICS INC | $45.77M | 44,873,646 | 47.80% | 52.20% | Net Buying | Net Buying | ||
| ALXO | ALX ONCOLOGY HOLDINGS INC | $21.70M | 53,444,020 | 65.13% | 27.88% | Net Selling | |||
| MDCX | MEDICUS PHARMA LTD | $39.14M | 13,494,861 | 22.53% | 71.99% | Net Selling | Net Selling | ||
| KPTI | KARYOPHARM THERAPEUTICS INC | $37.93M | 8,639,904 | 9.36% | 90.64% | Net Selling | Net Selling | ||
| MGX | METAGENOMI INC | $54.58M | 37,381,495 | 25.46% | 33.19% | Net Selling | Net Selling | ||
| CLNN | CLENE INC | $33.78M | 8,982,747 | 1.16% | 98.84% | Net Buying | Net Selling | ||
| CRBP | CORBUS PHARMACEUTICALS HOLDINGS INC | $90.55M | 12,236,767 | 45.00% | 55.00% | Net Buying | Net Selling | ||
| CRIS | CURIS INC | $22.70M | 10,462,250 | 7.55% | 92.45% | ||||
| CING | CINGULATE INC | $17.20M | 4,245,713 | 1.74% | 98.26% | Net Selling | |||
| CNTB | CONNECT BIOPHARMA HOLDINGS LTD | $55.56M | 55,561,056 | 5.09% | 0.00% | ||||
| ACRS | ACLARIS THERAPEUTICS INC | $159.17M | 108,281,239 | 58.99% | 41.01% | Net Buying | Net Selling | ||
| RCKT | ROCKET PHARMACEUTICALS INC | $272.58M | 107,737,919 | 59.15% | 40.85% | Net Selling | Net Buying | ||
| CMMB | CHEMOMAB THERAPEUTICS LTD | $22.07M | 377,256,460 | 0.99% | 4.49% | ||||
| IOVA | IOVANCE BIOTHERAPEUTICS INC | $564.35M | 333,934,387 | 18.09% | 81.91% | Net Selling | Net Buying | ||
| IPSC | CENTURY THERAPEUTICS INC | $44.72M | 86,158,758 | 34.32% | 45.52% | Net Selling | Net Selling | ||
| ALLO | ALLOGENE THERAPEUTICS INC | $258.10M | 218,730,809 | 71.61% | 28.39% | Net Selling | Net Selling | ||
| AMTX | AEMETIS INC | $130.12M | 55,369,358 | 9.24% | 90.76% | Net Buying | Net Buying | ||
| OCGN | OCUGEN INC | $287.36M | 292,031,295 | 26.27% | 10.45% | Net Selling | |||
| SABS | SAB BIOTHERAPEUTICS INC | $15.70M | 9,291,697 | 4.07% | 95.93% | ||||
| ANVS | ANNOVIS BIO INC | $39.95M | 19,486,231 | 10.71% | 15.46% | Net Buying | Net Buying | ||
| OMER | OMEROS CORP | $187.50M | 58,592,513 | 47.05% | 6.67% | ||||
| MRKR | MARKER THERAPEUTICS INC | $16.52M | 11,314,835 | 2.89% | 97.11% | Net Buying | |||
| ATOS | ATOSSA THERAPEUTICS INC | $113.54M | 129,170,004 | 21.95% | 11.04% | Net Buying | Net Buying | ||
| BDSX | BIODESIX INC | $36.64M | 146,563,031 | 36.42% | 55.77% | Net Buying | Net Buying | ||
| CMPS | COMPASS PATHWAYS PLC | $259.17M | 93,561,753 | 55.48% | 30.56% | Net Selling | |||
| TARA | PROTARA THERAPEUTICS INC | $111.12M | 38,581,863 | 47.68% | 52.32% | Net Selling | Net Buying | ||
| HUMA | HUMACYTE INC | $328.85M | 155,118,816 | 39.21% | 22.32% | Net Selling | Net Buying | ||
| TCRX | TSCAN THERAPEUTICS INC | $79.23M | 56,590,627 | 70.31% | 29.69% | Net Buying | Net Buying | ||
| IRD | OPUS GENETICS INC | $58.29M | 59,661,197 | 4.48% | 95.52% | Net Buying | |||
| KRRO | KORRO BIO INC | $112.97M | 9,390,492 | 25.62% | 74.38% | Net Buying | |||
| CRDL | CARDIOL THERAPEUTICS INC | $116.48M | 82,608,992 | 9.33% | 0.00% | ||||
| AVTX | AVALO THERAPEUTICS INC | $51.76M | 10,827,620 | 9.22% | 90.78% | Net Selling | |||
| VIR | VIR BIOTECHNOLOGY INC | $714.69M | 138,238,003 | 63.04% | 36.96% | Net Selling | Net Selling | ||
| EDSA | EDESA BIOTECH INC | $14.40M | 7,022,678 | 23.71% | 76.29% | Net Buying | |||
| ALMS | ALUMIS INC | $164.30M | 54,405,544 | 61.40% | 38.60% | Net Buying | Net Buying | ||
| ESPR | ESPERION THERAPEUTICS INC | $197.01M | 198,199,462 | 57.14% | 20.68% | Net Selling | Net Selling | ||
| CLSD | CLEARSIDE BIOMEDICAL INC | $59.84M | 77,708,536 | 11.34% | 35.27% | Net Buying | |||
| OTLK | OUTLOOK THERAPEUTICS INC | $53.71M | 33,568,023 | 3.41% | 96.59% | Net Buying | Net Buying | ||
| BMEA | BIOMEA FUSION INC | $68.01M | 37,572,250 | 55.29% | 44.71% | Net Buying | |||
| ENGN | ENGENE HOLDINGS INC | $187.05M | 51,105,201 | 68.33% | 31.67% | Net Buying |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.